Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

Por Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S
Publicado em 2013

Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI

Por Schmitz, A. M. T., Veldhuis, W. B., Menke-Pluijmers, M. B. E., van der Kemp, W. J. M., van der Velden, T. A., Viergever, M. A., Mali, W. P. T. M., Kock, M. C. J. M., Westenend, P. J., Klomp, D. W. J., Gilhuijs, K. G. A.
Publicado no PLoS One (2017)